This analysis examines the current position and future outlook for Roche in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-7 year sales forecasts for key drugs. An interactive forecasting and analysis tool provides continually updated quantitative and qualitative information
Reasons to Purchase
Learn which therapeutic areas are forecast to drive Roche’s growth to 2010
Benchmark Roche’s performance against key rivals in the ethical pharmaceutical sector
